EyePoint Pharmaceuticals, Inc. Quarterly Costs and Expenses in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
EyePoint Pharmaceuticals, Inc. quarterly Costs and Expenses history and growth rate from Q1 2023 to Q3 2024.
  • EyePoint Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $43.3M, a 46.2% increase year-over-year.
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $43.3M +$13.7M +46.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $44M +$12.2M +38.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $45M +$15.8M +53.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q3 2023 $29.6M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $31.9M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $29.2M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.